Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
1 day ago · BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has …
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
15 hours ago · BOSTON, January 30, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved …
Vertex Announces FDA Approval of JOURNAVX ... - Business Wire
15 hours ago · Vertex has established a wholesale acquisition cost for JOURNAVX in the United States of $15.50 per 50mg pill. Vertex is also evaluating suzetrigine in peripheral neuropathic …
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
15 hours ago · The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new …
FDA approves Vertex Pharmaceuticals' Journavx for acute pain
6 hours ago · Vertex Pharmaceuticals president and CEO Reshma Kewalramani stated: “With the approval of Journavx, a non-opioid, pain signal inhibitor and the first new class of pain …
FDA approves painkiller designed to eliminate risks of addiction ...
15 hours ago · The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new …
Vertex Pharmaceuticals announces FDA approval of Journavx
1 day ago · Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration has approved JOURNAVX, an oral, non-opioid, highly selective NaV1.8 pain …
FDA approves Vertex non-opioid painkiller drug Journavx
15 hours ago · The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
FDA approves Journavx, new non-opioid painkiller from Vertex
15 hours ago · Nonetheless, Vertex executives say Journavx’s ability to soothe pain without the risk of addiction will likely make it a blockbuster, a drug that generates sales of at least $1 …
FDA approves Journavx, first novel painkiller in more than 20 …
14 hours ago · Journavx works by intercepting pain signals before they reach the spinal cord, rather than acting directly on the brain. Vertex said the wholesale cost would be $15.50 per 50 …
- Some results have been removed